Spatz P, Chen X, Reichau K, Huber M, Mühlig S, Matsusaka Y, Schiedel M, Higuchi T, Decker M (2024)
Publication Type: Journal article
Publication year: 2024
Book Volume: 67
Pages Range: 6327-6343
Journal Issue: 8
DOI: 10.1021/acs.jmedchem.3c02285
The interleukin-8 receptor beta (CXCR2) is a highly promising target for molecular imaging of inflammation and inflammatory diseases. This is due to its almost exclusive expression on neutrophils. Modified fluorinated ligands were designed based on a squaramide template, with different modification sites and synthetic strategies explored. Promising candidates were then tested for affinity to CXCR2 in a NanoBRET competition assay, resulting in tracer candidate 16b. As direct 18F-labeling using established tosyl chemistry did not yield the expected radiotracer, an indirect labeling approach was developed. The radiotracer [18F]16b was obtained with a radiochemical yield of 15% using tert-butyl (S)-3-(tosyloxy)pyrrolidine carboxylate and a pentafluorophenol ester. The subsequent time-dependent uptake of [18F]16b in CXCR2-negative and CXCR2-overexpressing human embryonic kidney cells confirmed the radiotracer’s specificity. Further studies with human neutrophils revealed its diagnostic potential for functional imaging of neutrophils.
APA:
Spatz, P., Chen, X., Reichau, K., Huber, M., Mühlig, S., Matsusaka, Y.,... Decker, M. (2024). Development and Initial Characterization of the First 18F-CXCR2-Targeting Radiotracer for PET Imaging of Neutrophils. Journal of Medicinal Chemistry, 67(8), 6327-6343. https://doi.org/10.1021/acs.jmedchem.3c02285
MLA:
Spatz, Philipp, et al. "Development and Initial Characterization of the First 18F-CXCR2-Targeting Radiotracer for PET Imaging of Neutrophils." Journal of Medicinal Chemistry 67.8 (2024): 6327-6343.
BibTeX: Download